Compliance Processes for Life Science Products in Brazil, Russia, India, China markets - Company Establishment, Clinical Trials, Registrations, Renewals and Supply Chain Considerations

24 - 25 January 2013, San Diego, United States

Introduction

Brazil, Russia, India and China enhanced the alignment of their life science product regulations to global standards, an important step forward toward foreign access. This eliminated the conflicting standards that prevailed among provincial government agencies. Healthcare Authorities and regulatory systems have now made their requirements and procedures more transparent to industry partners.